Aclarion stock has crashed nearly 98% in a year, but CEO Brent Ness has a bold plan to save it. He told Stocktwits exclusively that the company is copying the success of AI medical tech firms like HeartFlow. The new 2026 strategy focuses on getting insurance coverage and proving the tech works to fix the company fortunes.